Strong Earnings and Higher Dividend Boosts Delta’s Second Quarter

To close out the week, Delta Airlines reported a record-setting second quarter that also beat Wall Street estimates, as earnings were boosted by stronger demand with the summer travel season now in full-swing. Accordingly, the Atlanta-based international airline reported an adjusted quarterly earnings of $2.35 per share on adjusted revenue of

FDA Fast Tracks RRMM Drug for Potential Combination Therapy

This week, the United States Food and Drug Administration gave Kayropharm Therapeutics accelerated approval for its oral therapy drug selinexor (Xpovio), to be used with the corticosteroid dexamethasone as a combination therapy for adults with relapsed/refractory multiple myeloma (RRMM) and have run out of treatment options.  Relapsed/refractory multiple myeloma is

Common Kitchen Sponge Viruses May Consume Tough Bacteria

New research presented this weekend at the annual American Society for Microbiology suggests that some viruses—which often populate kitchen sponges—are able to eat bacteria.   Of course, a kitchen sponge is consistently exposed to myriad microbes, which means that they each develop their own special microbiome of organisms, and particularly bacteria.  And,

Bristol-Myers Still Waiting For FTC Approval of Celgene Takeover

Shares of Bristol-Myers Squibb took a big dip to start the week after the group announced the US Federal Trade Commission (FTC) is still examining their proposed $74 billion acquisition of cancer specialist Celgene Corporation.  Offering to sell the company’s psoriasis business to move the deal forward, the FTC’s hesitancy seemed